Previous 10 | Next 10 |
2024-02-09 13:39:14 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...
2024-02-09 13:21:35 ET More on AstraZeneca AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation Ionis-AstraZeneca amyl...
2024-02-09 08:02:43 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...
Q2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency (1) , compared to Q2'23. Q2'24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and ~$75 million in Q2’24, increased 8% compared to Q2'23. ...
Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...
2024-02-08 11:38:41 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript EU drug regulators to assess potential impact of Catalent-Novo merger ...
2024-02-07 17:43:49 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent ticks lower amid report Indiana plant may have quality issues ...
2024-02-07 16:29:17 ET Summary We anticipate an FTC review for the Novo Holdings acquisition of Catalent, Inc. but see no grounds for blocking. Timetable risk due to regulatory approval under HSR Act. Attractive 10.2% gross spread with favourable probability of closing. ...
2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...
MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE: CTLT) (“Catalent”) has violated federal securities laws based on a report by Bloomberg alleging that inspectors from the U.S. Food and Drug Administ...
News, Short Squeeze, Breakout and More Instantly...
Catalent Inc. Company Name:
CTLT Stock Symbol:
NYSE Market:
Q3'24 net revenue of $1.07 billion increased 4% as reported, or 3% in constant currency (1) , compared to Q3'23. Q3'24 net revenue, excluding COVID-related revenue of ~$120 million in Q3’23 and ~$60 million in Q3’24, increased 11% compared to Q3'23. Q3'24...
Novo Nordisk A/S (NYSE:NVO) is witnessing a surge in the number of patients starting on its weight-loss drug, Wegovy, in the U.S. This increase com...
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...